Biotransformation of Medicinal Nanostructures: Pharmacokinetics and Pharmacodynamics
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Molecular Structure".
Deadline for manuscript submissions: closed (31 October 2022) | Viewed by 5087
Special Issue Editor
Special Issue Information
Dear Colleagues,
Molecules is now announcing a call for submissions to the Special Issue entitled “Biotransformation of Medicinal Nanostructures: Pharmacokinetics and Pharmacodynamics”. This issue will deal with the most recent achievements in basic research on molecular and cellular nanopharmacology and related subjects such as xenobiochemistry, drug metabolism, efficiency, and bioavailability of biologically active nanocompounds, drug–target interactions, ligand–receptor coupling, advanced methods in analytical biochemistry, and detection–quantification of nanopharmacophores. In silico simulation models would also be welcomed.
Some specific aspects of preclinical nanomedicine studies including in-cell internalization of pharmacophores, visualization of tumor, and nanocontainers in drug targeted delivery cases taken in a broad variety of pathologies (cancers, infectious diseases, autoimmune disorders, etc.) are also expected to be focused on—as long as these studies relate to nanodrug metabolism and its pharmacological potential.
Manuscript formats adopted by Molecules may additionally include the following types of papers: articles, reviews, communications, brief reports, etc.
Prof. Dr. Dmitry A. Kuznetsov
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Medicinal nanoparticles
- Drug targeting
- Pharmacokinetics
- Nanoparticle biotransformation
- Nanodrug–target coupling
- In silico nanopharmacodynamics models
- Advanced techniques in detection of nanodrugs in vivo
